Advertisement
340B showdown: Big pharma, hospitals squaring off in lobbying fight

340B showdown: Big pharma, hospitals squaring off in lobbying fight

By Susannah Luthi  |  July 21, 2018

Hospitals have adopted a take-no-prisoners approach in the fight with Big Pharma over the 340B drug discount program. Can this strategy hold as Congress, oversight agencies, the courts and the Trump administration ratchet up scrutiny of the program?

How to limit
 drug prices

How to limit
 drug prices

By Virgil Dickson  |  July 21, 2018

HHS received over 3,000 comments on the Trump administration's Blueprint to Lower Drug Prices, which was released in May. Hospitals, health insurers and drugmakers had plenty to say on how to address soaring drug prices

CMS may propose restarting $10B risk-adjustment payments

CMS may propose restarting $10B risk-adjustment payments

By Virgil Dickson  |  July 19, 2018

The CMS sent a rule to the White House for review that may resume risk-adjustment payments to insurers. Patient advocates have claimed the agency was trying to sabotage the insurance exchanges by eliminating billions in payments.

Drug rebates' legal protections are on the chopping block

Drug rebates' legal protections are on the chopping block

By Virgil Dickson  |  July 19, 2018

HHS is taking steps to remove legal protections for drug rebates that favor pharmacy benefit managers. It's unclear whether the changes will actually lead to lower drug prices, experts say.

Hospitals are flirting with Medicare for All

Hospitals are flirting with Medicare for All

By Susannah Luthi  |  July 19, 2018

House Democrats launched a Medicare for All caucus and its founder says some hospital leaders have been cautiously supportive behind closed doors.

4 takeaway questions as the Senate looks at healthcare costs

4 takeaway questions as the Senate looks at healthcare costs

By Susannah Luthi  |  July 17, 2018

The Senate Health, Education, Labor and Pensions Committee held its second hearing on healthcare spending Tuesday, with lawmakers and witnesses trying to drill down on big questions that could lead to concrete health policy.

Planned Parenthood loses bid to stall Title X funding changes

Planned Parenthood loses bid to stall Title X funding changes

By Susannah Luthi  |  July 17, 2018

A federal district judge rejected Planned Parenthood and the ACLU's bid to freeze the Trump administration's new funding criteria for the Title X family planning program, leaving the existing network of grantees in limbo.

Advertisement
винстрол купить

orlistat kaufen

dapoxetine 60mg

www.viagra-on.com
X

Subscribe and SAVE 50%